ARTICLE | Clinical News
Epidaza chidamide regulatory update
February 9, 2015 8:00 AM UTC
China approved Epidaza chidamide from Chipscreen to treat relapsed or refractory peripheral T cell lymphoma (PTCL). Gold NanoTech has exclusive rights to the small molecule histone deacetylase (HDAC) ...